Table 4

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016

Amrei Krings

, Josephine Jacob, Frank Seeber, Uwe Pleyer, Jochen Walker, Klaus Stark, and Hendrik Wilking

Author affiliations: Robert Koch Institute, Berlin, Germany (A. Krings, F. Seeber, K. Stark, H. Wilking); European Centre for Disease Prevention and Control, Stockholm, Sweden (A. Krings); InGef–Institute for Applied Health Research Berlin GmbH, Berlin (J. Jacob, J. Walker); Charité Universitätsmedizin Berlin, Berlin (U. Pleyer)

Main Article

Estimated incidence of cerebral toxoplasmosis manifestations by age group, sex, and region, Germany, 2016*

Characteristic	No. patients in database	No. patients in country (95% CI)	No. cases/100,000 population (95% CI)
Sex
M	5	108 (24–533)	0.3 (0.1–1.3)
F	5	92 (25–778)	0.2 (0.1–1.9)
Age group, y
<1 y	0	0	0
1–5 y	0	0	0
6–10 y	0	0	0
11–20 y	0	0	0
21–30 y	0	0	0
31–40 y	0	0	0
41–50 y	5	123 (29–395)	1.1 (0.3–3.4)
51–60 y	<5	NA	NA
61–70 y	<5	NA	NA
>71 y	<5	NA	NA
Region
East	<5	NA	NA
West	8	113 (46–319)	0.2 (0.1–0.5)
North	<5	NA	NA
Middle	<5	NA	NA
South	<5	NA	NA
Total	10	200 (74–883)	0.2 (0.1–1.1)

*Reference population N = 5,171,212. NA, not available.

Main Article

Page created: June 16, 2021

Page updated: July 18, 2021

Page reviewed: July 18, 2021

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.